Current Pharmacogenomics and Personalized Medicine
Title: Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)]
Volume: 9 Issue: 4
Author(s): Yann Joly, Richard G.H. Cotton, Eugene Kolker, Samer A. Faraj, Adam S. Ptolemy, Emmanuelle Vaast, Leela John, Yasemin Yazan, Candan Hizel, Ma'n H. Zawati, Vural Ozdemir, Edward S. Dove, Aresha Manamperi, Panga Jaipal Reddy, Ramy K. Aziz, Ghazi O. Tadmouri, Sanjeeva Srivastava, Louise Warnich and David S. Rosenblatt
Affiliation:
Keywords: Anticipatory ethics, Data-Enabled Life Sciences Alliance, DELSA, genomics without borders, global ethics and international development in pharmacogenomics, Human Variome Project, RaDiCAL, Rare Disease Consortium for Autosomal Loci
Export Options
About this article
Cite this article as:
Joly Yann, G.H. Cotton Richard, Kolker Eugene, A. Faraj Samer, S. Ptolemy Adam, Vaast Emmanuelle, John Leela, Yazan Yasemin, Hizel Candan, H. Zawati Ma'n, Ozdemir Vural, S. Dove Edward, Manamperi Aresha, Jaipal Reddy Panga, K. Aziz Ramy, O. Tadmouri Ghazi, Srivastava Sanjeeva, Warnich Louise and S. Rosenblatt David, Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)], Current Pharmacogenomics and Personalized Medicine 2011; 9 (4) . https://dx.doi.org/10.2174/187569211798377153
DOI https://dx.doi.org/10.2174/187569211798377153 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New and Emerging Antiresorptive Treatments in Osteoporosis
Current Drug Safety High Doses of In vitro Beta-carotene, Alpha-Tocopherol and Ascorbic Acid Induce Oxidative Stress and Secretion of IL-6 in Peripheral Blood Mononuclear Cells from Healthy Donors
Current Aging Science Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics
Current Cardiology Reviews Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Current Drug Targets A Mini-Review on Cardiovascular and Hematological Complications of COVID-19
Coronaviruses A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Muscular Gene Transfer Using Nonviral Vectors
Current Gene Therapy Prospective Clinical Applications of CRF Peptide Antagonists
Current Molecular Pharmacology Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets Giant Cell Arteritis - Beyond the Headache
Current Rheumatology Reviews Congenital Duodenal Obstruction: The Impact of Downs Syndrome in Neonatal Morbidity. A Two-Center Survey
Current Pediatric Reviews Therapeutic Aspects of Squill; An Evidence-Based Review
Current Drug Discovery Technologies Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Current Cardiology Reviews Tissue Factor and Atherothrombosis
Current Pharmaceutical Design MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Modulation of Angiotensin II Effects, A Potential Novel Approach to Inflammatory and Immune Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease
Current Pharmaceutical Design Interactions between Inflammation and Coagulation in Autoimmune and Immune-Mediated Skin Diseases
Current Vascular Pharmacology Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition